President Trump, alongside Health Secretary Robert F. Kennedy Jr., announced a new autism initiative that includes FDA approval of leucovorin (a folinic acid) for treating a subtype of autism, and issued a public warning about possible links between Tylenol use during pregnancy and increased autism risk—though medical experts stress the evidence is inconclusive and warn against panic. The move comes as the administration launches a national data effort to better track autism cases, treatments, and risk factors.
Get the latest stories Justin is looking at today in the Secret Show prep - Join the VIP Freedom Fam..
Only for Supporters
To read the rest of this article and access other paid content, you must be a supporter
